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Abstract: The economics of managing disease transmission at the wildlife–livestock interface
have received heightened attention as agricultural and natural resource agencies struggle
to tackle growing risks to animal health. In the ¿scal landscape of increased scrutiny and
shrinking budgets, resource managers seek to maximize the bene¿ts and minimize the costs
of disease mitigation efforts. To address this issue, a bene¿t-cost analysis decision framework
was developed to help users make informed choices about whether and how to target disease
management efforts in wildlife and livestock populations. Within the context of this framework,
we examined the conclusions of a bene¿t-cost analysis conducted for vampire bat (Desmodus
rotundus) rabies control in Mexico. The bene¿t-cost analysis decision framework provides
a method that can be used to identify, assemble, and measure the components vital to the
biological and economic ef¿ciencies of animal disease mitigation efforts. The framework can
be applied to commercially-raised and free-ranging species at various levels of management
– from detailed intervention strategies to broad programmatic actions. The ability of bene¿tcost analysis to illustrate the bene¿ts of disease management projects per dollar spent allows
for the determination of economic ef¿ciency of alternative management actions. We believe
this framework will be useful to the broader natural resource management community to
maximize returns on ¿nancial and other resources invested in wildlife and livestock disease
management programs.
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A natural outcome of human population
growth has been the juxtaposition of human
activities and enterprises with natural features
of the environment, including wildlife habitat.
Expanding zones of contact between animal
agriculture (e.g., livestock, captive wildlife, and
companion animals) and free-ranging wildlife
have arguably led to increasing risks to animal
health, both for domestic livestock and for
wildlife populations (Rhyan and Spraker 2010,
Miller et al. 2013).
Disease transmission at the wildlife–livestock
interface has the ability to signięcantly impact

human health, threaten global trade and
tourism, cause signięcant economic loss, and
provide a potential mechanism for bio-terrorism.
Evidence of these impacts can be seen through
the examples of brucellosis, tuberculosis, avian
inĚuenza virus H5N1, foot-and-mouth disease
(FMD), severe acute respiratory syndrome,
human African trypanosomiasis, rabies, and
anthrax.
Outbreaks of avian inĚuenza virus H5N1
in Africa, Asia, and Europe resulted in an
estimated loss to the poultry industry of $10
billion in 2005, as well as the destruction or loss
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of >200 million birds worldwide (FAO-OIE 2005,
2007). Epizootics of FMD in Taiwan and Great
Britain illustrate the potentially devastating
economic impacts of infectious disease transfer
to livestock markets. In 1997, the number of
FMD positive cases in Taiwan reached 1 million
swine and >3.85 million animals were destroyed
(Yang et al. 1998). The highly contagious nature
of FMD led to an export ban on pork from
Taiwan in March of 1997. Prior to the outbreak,
the country exported >$1.6 billion annually,
accounting for 15% of global pork exports.
Over a decade aĞer the outbreak, Taiwan had
not regained its high level of exports and had
much lower hog populations, while the United
States, Canada, and Denmark increased their
pork export market share as a result (Blayney
et al. 2006). A 2001 outbreak of FMD in Great
Britain resulted in estimated losses of £3.1
billion to the agriculture and food production
sectors with additional tourism losses at least
as great. It has been estimated that if FMD were
to enter the United States, the economic losses
would range from $12 billion to $228 billion
with >30% of domestic livestock destroyed
depending on the size and level of containment
of the outbreak (Paarlberg et al. 2002, Boisvert
et al. 2012, Oladosu et al. 2013).
In the United States, 79% of the livestock
diseases that are reportable to the World
Organisation for Animal Health have a wildlife
component associated with their transmission,
maintenance, or life cycle (Miller et al. 2013).
The pathway to economic impact of disease
transmission at the wildlife–livestock interface,
hereaĞer referenced as “the interface,” is usually
from wildlife to livestock. But, the opposite
case can become economically important
when it helps maintain the disease reservoir
in wildlife. A convergence of factors including
land use changes, increasing frequency of
contact between livestock and free-ranging
wildlife, climate change, and the growth and
intensięcation of livestock production have
increased the need for a systematic process to
understand the economics of controlling disease
transmission at the interface (Jones et al. 2013).
The monetary burden of disease transmission
at the interface can be broadly divided into
the impacts to livestock production, impacts
to human and wildlife health, changes to
consumption demand, and costs associated
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with disease management or mitigation.
The interfaces between wildlife, domestic
animals, and humans provide many avenues to
create economic losses resulting from disease
transmission. OĞen, the most direct or immediate
impact of wildlife disease transmission is the
eěect on livestock populations (Cleaveland et
al. 2001, Tschopp et al. 2010, IFAH 2012, Narrod
et al. 2012). Livestock morbidity and mortality
cause direct losses within the livestock sector,
and these losses in turn negatively impact
economic sectors that are linked to livestock
production. Additionally, consumer spending
and tax revenue may be aěected as prices and
spending paĴerns change.
Human health impacts from zoonotic disease
transmission can result from infectious contacts
with wildlife or livestock, both of which may
also exchange pathogens with one another prior
to spillover into humans (Jones et al. 2013).
Regardless of the pathway, the human health
burden from zoonotic disease transmission
has been well documented and includes
death, illness, and disability (Cleaveland et
al. 2001, Jones et al. 2013). Estimates of costs
associated with these eěects are available in
the literature and can have broader economic
implications as aěected individuals, businesses,
and governments reallocate resources to pay
for treatment costs.
Consumers oĞen react very quickly to real
or perceived threats to human health and food
safety and may avoid certain food products
or tourist areas that are perceived as risky.
These behaviors can be devastating to the
economy. For example, in 2009, as pandemic
H1N1 inĚuenza spread into the United States,
domestic pork consumption fell and exports
from the United States decreased. Additionally,
Russia and China, which represented almost
30% of the U.S. pork export market prior to
the 2009 outbreak, banned the importation
of certain types of pork products from the
United States. As a result of reduced domestic
pork consumption and declining pork prices,
the U.S. pork industry lost an estimated $270
million in income in the second quarter of 2009
(Johnson 2009).
The main purpose of disease management at
the interface is to reduce or eliminate the risk of
disease transmission from wildlife to livestock.
Success can be measured as the damage (i.e.,
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losses, costs, etc.) avoided or in terms of the
number of protected individuals, including
humans, livestock, wildlife, and companion
animals (Kapos et al. 2008). Management
strategies are diverse and focus primarily
on livestock populations (e.g., biosecurity
measures, vaccination, husbandry practices).
However, a few examples exist of disease
management in wildlife populations. These
include bovine tuberculosis (bTB, caused
by Mycobacterium bovis), bovine brucellosis
(caused by Brucella abortus), and rabies (caused
by Lyssavirus spp.).
Individual producer estimates of the beneęts
and costs of management strategies are crucial
to disease control eěorts to gain producer
involvement in mitigation eěorts. Individual
producer resources are limited, and investment
in disease management will depend on the
size of the operation, available resources,
intended market of the ęnished product,
education level of the producer, and production
technology (Hennessy 2005, 2007; Beach et al.
2007). However, within any private market,
producers will choose to invest in a particular
management strategy up to the point where
the expected private marginal beneęts equal
the expected private marginal costs (Beach et
al. 2007). By their very nature, private markets
provide neither an incentive nor a mechanism
by which producers would consider the
greater social costs or beneęts of their disease
management actions. As a result, one would
expect private producers to under-invest
in management from a social point of view
(McCarthy et al. 2003). Because the broader
society would prefer greater investment in
disease management, this outcome is referred
to as a “market failure.”
Unlike individual producers, governments
are expected to consider the total beneęts and
costs of disease transmission and mitigation.
Disease management programs initiated by
governments seek to achieve the optimal level
of disease control by factoring in a broader set
of components, including the impacts to overall
disease containment in a region, impacts to
wildlife and human health, and market impacts
to consumers and the macroeconomy (Beach et
al. 2007). Regardless of who initiates disease
management at the interface, the economically
eĜcient implementation of management eěorts
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requires a comprehensive understanding of
savings derived from a reduction in disease
transmission.
In this paper, we provide a decision
framework for beneęt-cost analyses of disease
transmission mitigation at the wildlife–
livestock interface. Our methodology considers
the potential impacts of disease mitigation
to public health, animal health, and the
economic sectors of a particular region. We
illustrate the use of this framework by applying
it to a previously conducted beneęt-cost
analysis, which evaluated a variety of disease
transmission management options for a specięc
disease.

Methods

Development of a beneÀt-cost analysis
decision framework for disease
management
A general decision framework was
developed for conducting beneęt-cost analyses
of management actions designed to reduce the
risk of disease transmission at the wildlife–
livestock interface (Figure 1). This framework
is designed to measure and compare the value
of management actions in terms of the direct
beneęts to impacted sectors (livestock, wildlife,
humans, and their companion animals) and
costs resulting from the management actions
chosen to mitigate disease transmission in
wildlife and livestock populations. When
aĴempting to reduce disease transmission at
the interface, wildlife and livestock managers
are faced with a suite of management options.
Livestock-focused
management
options
include conęnement of livestock or exclusion
of wildlife through fencing or other means,
improving biosecurity of farms, culling,
livestock vaccination/treatment, and other
husbandry practices (e.g., separation of sick
animals) to manage disease. Wildlife-focused
management options include population
reduction, wildlife vaccination, and hazing of
wildlife from livestock use areas. All disease
management strategies have costs. The goal
of these strategies is to reduce the probability
of disease transmission at the interface, so the
costs may be partially or completely oěset by
the value of reduced damage.
To measure economic eĜciency, the
framework allows for the quantitative
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Figure 1. Decision-making framework for bene¿t-cost analysis of disease management options at the
wildlife–livestock interface. Bene¿ts (damages avoided) consist of consumption demand losses avoided
(DAK), human health losses avoided (DAH), livestock losses avoided (DAL), and wildlife losses avoided (DAW).

or qualitative comparison of alternative
management strategies resulting in reduced
disease transmission between wildlife and
livestock populations. Beneęt-cost analysis
is a commonly used tool to evaluate program
activities by identifying and comparing the
beneęts and costs of alternative management
eěorts (Nas 1996). Another metric, costeěectiveness analysis, may be used when
beneęts of alternate management programs are
similar but diĜcult or impossible to monetize
(Boardman et al. 1996). For example, costeěectiveness analysis would be appropriate for
a disease management project that captures the
costs and number of animals saved associated
with each management eěort but is unable to
make any animal valuation estimates. Economic
eĜciency is achieved through the management
approach that produces the greatest net
present value of the beneęts (Cullen et al. 2001;
Engeman et al. 2002, 2003; Cullen et al. 2005;
Caudell et al. 2010; Laycock et al. 2011).
Determining management costs. Costs (Ci),

driven by management actions (i = 1, . . . , n),
are oĞen more straightforward to quantify
than beneęts (Shwiě et al. 2013a). The general
category of management costs associated with
wildlife disease transmission mitigation can
be broken down into operational (Ops) and
spillover (Spill) costs (Figure 1), represented by:

Operational costs represent the ęnancial
costs of project implementation and typically
involve land purchase/lease, land management,
equipment,
labor,
supplies,
planning,
negotiating, and other costs crucial to project
completion and management. These costs
can be obtained by keeping ęnancial records
of all aspects of expenditures related to the
project for a post-project assessment of costs.
Spillover costs are burdens external to a project
and can include costs that arise from reduced
agricultural production, lost recreational
opportunities, loss of competing species or
habitat, increased human conĚicts, and other
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forgone uses of impacted wildlife species
(Naidoo et al. 2006).
Assigning beneęt values. Estimating the total
beneęts of preventing or reducing disease
spread from wildlife to livestock requires
quantięcation of market and non-market goods
and services. An accepted methodology for
determining these values is the damage avoided
method, which uses the value of resources
saved as a measure of beneęts provided by the
disease management program. In the current
context, loss avoided is a function of 2 things: 1)
impacts of a disease on livestock and/or wildlife
in the absence of any management intervention,
and 2) how eěectively a particular management
option in either wildlife or livestock reduces
the probability (Ε) of disease impacts. Disease
impacts may be estimated using stochastic
simulation models or deterministic models,
either in advance of an outbreak or aĞer the
outbreak occurs. Discussion of the factors
that play a role in disease impacts are outside
the scope of this manuscript, but include
aěected livestock and wildlife species,
disease prevalence and susceptibility of host
populations, contact rates between potential
hosts, pathogen virulence and transmissibility,
severity of clinical infection, presence of
reservoir and carrier species, zoonotic potential,
and the eěectiveness of particular management
options. The general framework presented
in Figure 1 allows users to insert underlying
equations and assumptions to parameterize the
framework’s variables.
Damage avoided (beneęts) consist of 4
general components: consumption demand
losses avoided (DAK), human health losses
avoided (DAH), livestock losses avoided (DAL),
and wildlife losses avoided (DAW), and their
monetary valuations, ·. This relationship is
represented by the following equation, where
i = 1, . . . , n represents the management actions
being evaluated.

For example, if 2 management options are
being considered—1 in wildlife populations
(e.g., vaccination) and 1 in livestock populations
(e.g., fencing)—then ΆW V would represent the
beneęts derived from the 4 components (DAK,
DAH, DAL, DAW) through vaccination of
wildlife populations, while ΆLF would measure

95
the beneęts derived from fencing around
livestock facilities.
Damage avoided valuation (·) is dependent
upon the component being valued. Valuation
of consumption demand losses avoided (·K)
is a function of reduced consumption demand
(domestic and international) for livestock
products due to real or perceived threats to
human health or food safety. This variable
represents a reduction in quantity demanded
(a shiĞ in the demand curve) for the aěected
commodity and can be quantięed by a change
in consumer surplus with special care taken
to avoid any possible double counting. The
ability of individual consumers to substitute
away from certain livestock products, as well
as consumer taste and preferences, inĚuence
the size of this variable. Export bans, supply
constraints, and movement restrictions can
aěect consumer ability to purchase the livestock
product.
Valuation of human health loss avoided
(·H) is a function of disease morbidity and
mortality in humans and direct and indirect
costs of disease management. We include
companion animals in this variable. Therefore,
if the disease is not zoonotic, this variable will
reĚect only companion animal costs. Direct
costs include medical treatment expenses and
reduced quantity and quality of human health
(Jones et al. 2013). Many established methods
exist to value direct losses to human health
including quality-adjusted-life years (QALY),
disability-adjusted-life years (DALY), or valueof-statistical life (VSL; Shwiě et al. 2013b). Both
QALY and DALY measurements are expressly
designed to estimate the impacts to human
health as a result of disease burden. VSL
provides a measure of the marginal value of a
change in human mortality risk. Indirect costs
include lost work time and companion animal
impacts (Shwiě et al. 2007).
In terms of disease transfer at the interface,
livestock losses are commonly reported as the
most signięcant source of economic impact
(IFAH 2012). Livestock mortality (·L) loss is
based on the market value of the animal at time
of death while morbidity loss can be calculated
from the value of reduction in weight, decreased
production, or increased veterinary costs.
Given that free-ranging wildlife typically do
not have deęned market values, valuation of
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wildlife (·W) can occur through survey methods,
such as the contingent valuation method and
travel cost method (TCM), as well as nonsurvey methods, such as beneęt-transfer. The
contingent valuation method is a survey-based,
stated preference approach to estimate use
and existence values associated with wildlife
species (Kotchen and Reiling 1998). This
method solicits responses from individuals
regarding their willingness to pay for increased
wildlife populations. By varying the amount
that respondents are asked to pay, a social value
of the outcome is constructed (Loomis 1990).
TCM is another survey approach, which uses
costs incurred for travel to quantify demand
for recreational activities linked to a species
of interest (Kotchen and Reiling 1998). TCM is
based on the idea that as some environmental
amenity changes, the amount that people are
willing to pay to use it will change, and that
the change in willingness to pay is revealed by
a change in travel costs. The beneęt-transfer
method relies on beneęt values derived from
the contingent valuation method and TCM
studies in 1 area, which can be transferred
to similar species at another location while
adjusting the values for diěerences in incomes
or prices between locations.
Beneęt-cost ratios. Combining the relevant
information on beneęts and costs allows the
calculation of beneęt-cost ratios (BCRs). Net
beneęts can be calculated by subtracting the
denominator from the numerator.

conducted a bene¿t-cost analysis to evaluate these 2
mitigation strategies. We examined the methodology
and conclusions of that analysis within the context
of our framework.
Inclusion of speci¿c bene¿ts and costs depend
on who is given standing, or whose perspective is
being considered. In this case, private bene¿ts and
costs are those that accrue to livestock producers.
A broader examination of the social bene¿ts and
costs considers not only impacts to producers, but
also reductions in the use of human post-exposure
prophylaxis and animal tests, which bene¿t
individuals not necessarily involved in livestock
production. To account for uncertainty in the true
value of these parameters, Anderson et al. (2012)
conducted Monte Carlo simulations, estimating
a range of parameter values. These variables
were applied to our bene¿t-cost analysis decision
framework and are presented in Table 1, along with
the analogous variables used in our framework. The
bene¿t-cost analysis framework applied to this data
is presented in Figure 2.
Three vampire bat rabies management
scenarios are considered in this study. In the
¿rst, the producer is given standing so only
the costs from cattle pre-exposure vaccination
and the bene¿ts derived from that vaccination
are factored into the decision making process.
Producer management costs are operational and
consist of the total quantities of vaccine, coolers,
ice, and fuel multiplied by their prices (OpsL).
Bene¿ts are based on the cattle population (N)
and the market price of cattle (ȖL) as well as the
reduction in disease impacts (ȡL), which is a
function of rabies-related cattle mortality (M) and
vaccine effectiveness (V).
The bene¿t-cost ratio (BCR) for the producer is
BCR estimates of >1.0, or positive net beneęts, determined by the following equation:
indicate that the proposed management actions
would be economically eĜcient.

Application of the framework to
vampire bat rabies in Mexico
Vampire bat rabies causes signi¿cant impacts
within its endemic range in Mexico. Animal testing
costs, post-exposure prophylaxis costs, human
mortality risk, and cattle losses comprise most of
the economic costs associated with vampire battransmitted rabies in Mexico (Arambulo and Thakur
1992). Mitigation of the impacts can be achieved
by 2 approaches: cattle vaccination and vampire
bat population control. Anderson et al. (2012)

From a social perspective, there are 2 publicly
funded strategies available to mitigate vampire
bat rabies disease impacts. First, vampire bat
populations can be reduced to decrease the
likelihood of vampire bat contact with humans
and animals, consequently reducing the number
of post-exposure prophylaxis and animal tests.
Second, public funding could be used to control
vampire bat populations as well as subsidize
caĴle vaccination, which would reduce the
number of post-exposure prophylaxis and
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Figure 2. Bene¿t-cost analysis framework for vampire bat rabies management from producer and social
perspectives. DAH indicates human health losses avoided; DAL indicates livestock losses avoided.

animal tests and would reduce caĴle mortality. mitigation and reap the beneęts, and 2 social
The ęrst option is characterized by:
options in which costs and beneęts extend
beyond producers to the broader society. The
ęrst social option involved vampire bat control,
and the second option added subsidized caĴle
The second option combines management vaccination.
of livestock and wildlife populations and
Under the private mitigation scenario, mean
is characterized by the following equation. beneęt-cost ratios ranged from 6.42 to 6.64 for
Because livestock vaccination is subsidized the producer, indicating that for every $1 the
in this scenario, the social beneęts of reduced producer spent to vaccinate caĴle, >$6 in beneęts
were received. In other words, the return to
animal tests are included.
producers in terms of reduced caĴle mortality
was >6 times the investment in vaccination.
Clearly, from the producer’s perspective,
vaccinating caĴle to reduce livestock mortality
is economically eĜcient.
Beneęt-cost ratios for the ęrst social
management option, bat population reduction,
Results
ranged from 0.36 to 0.38. This result indicated
Anderson et al. (2012) calculated beneęt- economic ineĜciency in that for every $1 spent
cost ratios for 3 alternative vampire bat rabies on the program, <$1 was returned in beneęts.
mitigation programs: a private option in which In contrast, including all the beneęts and costs
livestock producers bear the cost of rabies accrued by managing vampire bat rabies in both

Human–Wildlife Interactions 10(1)
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Tb 1. Variables used by Anderson et al. (2012) with analogous beneęt-cost analysis framework
variables.
Anderson et al. variables

Beneęt-cost analysis framework variables

Variable

Description

Variable

Description

N

CaĴle population

N

CaĴle population

M

CaĴle mortality rate

V

Vaccine eěectiveness

ΕL

Decrease of caĴle disease impacts as a result
of livestock vaccination

PEP

% PEP avoided

ΕPEP

Decrease in disease impacts to humans as a
result of bat control

AT

% AT avoided

ΕAT

Decrease in disease impacts to humans as a
result of vaccine subsidies

Pn

Market price of caĴle

·L

Market price of caĴle

Ppep

Unit cost of PEP

·PEP

Price of PEP

Pat

Unit cost of animal tests

·AT

Price of AT

Qpep

Quantity of PEP

QPEP

Quantity of PEP

Qat

Quantity of animal tests

QAT

Quantity of AT

Pv

Unit cost of vaccine

Qv

Quantity of vaccine

Pc

Unit cost of coolers

Qc

Quantity of coolers

OpsL

Livestock vaccination program cost

Pi

Unit cost of ice

Qi

Quantity of ice

Pf

Unit cost of fuel

Qf

Quantity of fuel

B

Bat control program cost

OpsW

Bat control program cost

wildlife and livestock populations returned
mean BCRs that ranged from 6.32 to 6.52.
Using our framework to map out the
pathways by which beneęts are derived and
costs incurred allows for the straightforward
understanding of variables involved in the
determination of economic eĜciency. When
only operational costs and beneęts to livestock
and/or human health are considered, the results
clearly indicate that the economically eĜcient
management of vampire bat rabies consisted
of intervention on the livestock side of the
interface. This was the case whether rabies
management is undertaken by producers or in

the public sector. Intervention on the wildlife
side of the interface is economically ineĜcient.
Insight is gained through the framework in
that results can be framed in the context of
omiĴed components, and policy makers can
determine the validity of the results given their
valuation of the relative importance of the
omiĴed variables. In this analysis, the impacts
to consumer demand as well as the overall
impact of rabies to vampire bat populations
are likely to be negligible; therefore, even with
the inclusion of information regarding these
variables, the results are expected to remain
valid.
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Discussion
This manuscript provides a systematic
framework to evaluate objectively the economic
eĜciency of methods to mitigate disease
transmission at the wildlife–livestock interface.
This method allows for comparisons of multiple
management strategies across regions, diseases,
types of livestock, and wildlife species. The
utility of this framework is its Ěexibility; the
general components that should be present in a
beneęt-cost or other economic analysis of disease
management strategies are provided. Users can
insert underlying equations and assumptions
to inform the framework’s variables. Modeling
soĞware can be used to simulate factors such as
probability of disease transmission, estimates of
morbidity and mortality losses for a particular
disease, susceptibility of livestock populations,
probability
of
pathogen
transmission,
likelihood of clinical infection, and others.
Conversely, the framework can be simplięed
in the absence of sophisticated parameter
estimates. This approach can be used to
provide more qualitative estimates of the
components in the framework to obtain a
less rigorous estimation of potential impacts
and management costs. The level of rigor
provided by the framework is a function of
data availability. Additional Ěexibility in the
framework allows it to be adapted to other
seĴings, for example, to examine impacts at
the wildlife–human interface or the wildlife–
companion animal interface. This analysis
focuses primarily on quantifying the impacts of
disease transmission from wildlife to livestock;
however, disease transmission from livestock
to wildlife can also have costly implications.
Livestock production in the United States
is interconnected and concentrated. Disease
threats to food safety or livestock health have
the potential to quickly ripple through a region,
pushing impacts beyond livestock producers
to the entire U.S. economy. Additionally, real
or perceived risks to human health including
direct contact with diseased animals as well
as consumption of contaminated meat, dairy,
or poultry products may result in broader
economic impacts, some of which may be long
lasting.
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have resulted in limited resources to mitigate
disease threats in the United States, emphasizing
the need to use these resources eĜciently by
employing management strategies that will
provide the biggest return on investment. The
beneęt-cost analysis framework described here
can be used to identify, assemble, and measure
the components critical to the economic
eĜciency of animal disease mitigation eěorts.
In many cases, a lack of data, or inability to
quantify beneęts, may drive economic analyses
toward a simpler method, such as costeěectiveness analysis. Given the importance
and potential impacts of disease transmission at
the wildlife–livestock interface, we created this
methodology to aid in maximizing the return
on resources invested in disease management
programs.
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